Vimarsana
Biggest News Aggregation in the World

Page 29 - Oral Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oral Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oral Solution Today - Breaking & Trending Today

Nepal bans import of medicines from 16 Indian companies, including Patanjali's Divya Pharmacy, Zydus - Vimarsana News

Nepal bans import of medicines from 16 Indian companies, including Patanjali's Divya Pharmacy, Zydus

The move comes after the WHO issued an alert on Indian-made cough syrups, which were allegedly responsible for the deaths of children in Gambia.

Maiden Pharmaceuticals: India defends cough syrups linked to Gambia child deaths - Vimarsana News

Maiden Pharmaceuticals: India defends cough syrups linked to Gambia child deaths

India's drug regulator says lab tests haven't shown any evidence of contamination in the four cough syrups.

Source: bbc.co.uk
India defends cough syrups linked to Gambia child deaths - Vimarsana News

India defends cough syrups linked to Gambia child deaths

India has said that four cough syrups linked to child deaths in the Gambia were found to be complying with safety specifications when tested at home.

Maiden Pharma row: No contamination found in syrups linked to 66 children's deaths in Gambia, India tells WHO - Vimarsana News

Maiden Pharma row: No contamination found in syrups linked to 66 children's deaths in Gambia, India tells WHO

Earlier this year, Haryana-based pharmaceutical company Maiden Pharma came under scanner for its four syrup products which were linked to the deaths of 66 children in The Gambia. 

ANI Pharma: FDA Approves ANDA For Fluoxetine Oral Solution - Vimarsana News

ANI Pharma: FDA Approves ANDA For Fluoxetine Oral Solution

WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) announced Monday that the company received U.S. Food and Drug Administration approval for the Abbreviated New Drug Application or ANDA for